Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prograf vs Cyclosporine in Renal Allograft Failure Risk
NCT00510913Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Feb 1999
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in chronic renal allograft failure (CAF), sponsored by Astellas Pharma. Started Feb 1999; status: completed.
02
Drugs
tacrolimus
03
Conditions
chronic renal allograft failure (CAF)
Beyond the preview
Go deeper on NCT00510913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00510913.